KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Operating Leases (2019 - 2025)

Historic Operating Leases for Neogenomics (NEO) over the last 8 years, with Q4 2025 value amounting to $67.6 million.

  • Neogenomics' Operating Leases rose 1110.6% to $67.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $67.6 million, marking a year-over-year increase of 1110.6%. This contributed to the annual value of $67.6 million for FY2025, which is 1110.6% up from last year.
  • Neogenomics' Operating Leases amounted to $67.6 million in Q4 2025, which was up 1110.6% from $64.3 million recorded in Q3 2025.
  • Neogenomics' Operating Leases' 5-year high stood at $79.3 million during Q3 2021, with a 5-year trough of $51.5 million in Q1 2021.
  • Over the past 5 years, Neogenomics' median Operating Leases value was $66.0 million (recorded in 2023), while the average stood at $65.8 million.
  • Its Operating Leases has fluctuated over the past 5 years, first surged by 7091.21% in 2021, then crashed by 1201.06% in 2023.
  • Neogenomics' Operating Leases (Quarter) stood at $72.3 million in 2021, then decreased by 4.62% to $69.0 million in 2022, then fell by 1.57% to $67.9 million in 2023, then fell by 10.36% to $60.8 million in 2024, then grew by 11.11% to $67.6 million in 2025.
  • Its Operating Leases stands at $67.6 million for Q4 2025, versus $64.3 million for Q3 2025 and $66.6 million for Q2 2025.